Financial reports
10-Q
2019 Q3
Quarterly report
7 Nov 19
10-Q
2019 Q2
Quarterly report
8 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
7 Mar 19
10-Q
2018 Q3
Quarterly report
7 Nov 18
10-Q
2018 Q2
Quarterly report
8 Aug 18
10-Q
2018 Q1
Quarterly report
2 May 18
10-K
2017 FY
Annual report
22 Feb 18
10-Q
2017 Q3
Quarterly report
1 Nov 17
10-Q
2017 Q2
Quarterly report
8 Aug 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
28 Jan 20
8-K
Other Events
24 Jan 20
8-K
Other Events
16 Jan 20
8-K
Achillion Shareholders Approve Agreement to be Acquired by Alexion
19 Dec 19
8-K
Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7 Nov 19
8-K
Alexion to Acquire Achillion
16 Oct 19
8-K
Entry into a Material Definitive Agreement
17 Sep 19
8-K
Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate Update
8 Aug 19
8-K
Amendments to Articles of Incorporation or Bylaws
3 Jun 19
8-K
Regulation FD Disclosure
17 May 19
Registration and prospectus
15-12B
Securities registration termination
7 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 20
Proxies
DEFA14A
Additional proxy soliciting materials
2 Dec 19
DEFM14A
Proxy related to merger
21 Nov 19
DEFA14A
Additional proxy soliciting materials
20 Nov 19
DEFA14A
Additional proxy soliciting materials
7 Nov 19
PREM14A
Preliminary proxy related to merger
5 Nov 19
DEFA14A
Additional proxy soliciting materials
17 Oct 19
DEFA14A
Additional proxy soliciting materials
16 Oct 19
DEFA14A
Additional proxy soliciting materials
16 Oct 19
DEFA14A
Additional proxy soliciting materials
15 Apr 19
DEF 14A
Definitive proxy
15 Apr 19
Other
EFFECT
Notice of effectiveness
3 Feb 20
EFFECT
Notice of effectiveness
3 Feb 20
EFFECT
Notice of effectiveness
3 Feb 20
EFFECT
Notice of effectiveness
3 Feb 20
UPLOAD
Letter from SEC
21 Nov 19
CORRESP
Correspondence with SEC
18 Nov 19
UPLOAD
Letter from SEC
15 Nov 19
EFFECT
Notice of effectiveness
28 Apr 17
CORRESP
Correspondence with SEC
26 Apr 17
UPLOAD
Letter from SEC
9 Feb 17
Ownership
SC 13G/A
DIMENSIONAL FUND ADVISORS LP
16 Feb 21
SC 13G
Achillion Pharmaceuticals Inc
14 Feb 20
SC 13G/A
Achillion Pharmaceuticals Inc
14 Feb 20
SC 13G/A
Beneficial ownership report (amended)
12 Feb 20
SC 13G/A
Achillion Pharmaceuticals Inc
12 Feb 20
SC 13G/A
Achillion Pharmaceuticals Inc
10 Feb 20
4
Change in insider ownership
30 Jan 20
3
Initial statement of insider ownership
30 Jan 20
4
NICOLE VITULLO
29 Jan 20
4
Steven Zelenkofske
29 Jan 20